Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01866917 · ClinicalTrials.gov registry record · Phase 1
Study of TAP and Laparoscopic and Robotic Gynecologic Procedures and Obese Women
A Phase 1 study, sponsored by Montefiore Medical Center.
- Terminated
- Registry status
- Phase 1
- Development phase
- 35
- Enrollment target
NCT01866917 is a Phase 1 study that was terminated before completion, run by Montefiore Medical Center. The registered enrollment target is 35 participants.
The verdict
NCT01866917, a Phase 1 study, was terminated before completion, sponsored by Montefiore Medical Center.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 35 participants
- Enrollment target
Study Summary
Study the effect of the Transversis Abdominis Plane (TAP) block on pain after surgery for obese women undergoing laparoscopic or robotic gynecologic procedures.
Interventions
- DRUG Placebo
- DRUG Ropivacaine 0.5% 20cc injectate bilaterally
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2013-04 |
| Est. Completion | 2016-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01866917
The ClinicalTrials.gov registry entry for NCT01866917 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01866917 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01866917 about?
NCT01866917 is a clinical study titled "Study of TAP and Laparoscopic and Robotic Gynecologic Procedures and Obese Women". Study the effect of the Transversis Abdominis Plane (TAP) block on pain after surgery for obese women undergoing laparoscopic or robotic gynecologic procedures.
What is the current status of trial NCT01866917?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 35 participants. The study started on 2013-04. Estimated completion is 2016-04.
What interventions are being tested in trial NCT01866917?
The interventions under investigation include: Placebo (DRUG), Ropivacaine 0.5% 20cc injectate bilaterally (DRUG).
Who is sponsoring clinical trial NCT01866917?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.